ArticleCancer medicine2019

Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosis.

Novella Pugliese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.